Fluorescence based miniaturized microfluidic and nanofluidic systems for biomedical applications.

Over the last two decades miniaturized microfluidic and nanofluidic systems with fluorescence setup emerged as a powerful technological platform for diverse biomedical applications. Bio-macromolecules such as nucleic acids and proteins are the core cellular components, their single molecule analysis allow us to understand biological processes, disease creation and progression, and development of novel treatment policies. Design and development of foolproof treatment methods requires rigorously analysis of nucleic acids and proteins such as length quantifications, sequence profiling, sequence mapping, analysis of conformational changes, analysis and recognition of epigenetic changes, and their interactions with other biomolecules. Miniaturized microfluidic and nanofluidic systems with fluorescence spectroscopy enable worldwide researchers to perform nucleic acids and proteins extractions and single molecule analysis from the trace amount of biological samples. In the present chapter we mostly highlighted over one decade applications of microfluidic and nanofluidic systems for single cell micro ribonucleic acid (miRNA) isolation and detection, deoxyribonucleic acid (DNA) mapping, DNA barcoding, identification of epigenetic mark on single DNA molecule, DNA-protein interactions study, protein sensing, protein sequencing, protein binding kinetics and many other applications. We also presented the recently reported microfluidic platform for the preparation of reproducible unisize aggregation induced emission (AIE) active nanomaterials and their biological applications.

AIE materials for nucleus imaging.

Emergence of a captivating phenomenon aggregation induced emission (AIE) in the early years of 21st century attracted worldwide researchers. In the last two decades various novel AIE active biocompatible small molecules, macromolecules and polymers have been developed for diverse biomedical applications. Imaging of specific organelle such as mitochondria, ribosomes, nuclei and many others play important in the controlling and successful treatment of various diseases. Conventional luminescent probe molecules used in the imaging at cellular or subcellular level exhibit very weak emission on dispersion or on aggregation in aqueous media. AIE luminogens development is indispensable to overcome the notorious aggregation-caused quenching (ACQ) issue inherited by conventional fluorophores. In the present chapter we mostly highlighted over one decade development of various AIE active luminogens utilized for imaging of cell nucleus, nucleon and nucleic acids. The development of those AIE luminogens exhibits promising results in the early diagnosis of cancer diseases.